Monitoring Protocol for Clozapine-induced Myocarditis. Copyright 2017, CAMH
|
|
- Natalie Tiffany Robinson
- 5 years ago
- Views:
Transcription
1 1 Monitoring Protocol for Clozapine-induced Myocarditis 1
2 Agenda Problem Identification / Identification Importance / Importance Baseline Workflow Baseline Workflow Baseline Data Baseline Data Objectives Solution Selection Interventions Interventions End-User Involvement End-User Involvement Revised Workflow Solution Details Effect of Interventions on Data Post- Adherence Data Post- Outcome Data Return on Investment 2
3 Overview of Clozapine 25-30% of all individuals with schizophrenia meet criteria for treatment resistance (Remington 2010) Clozapine is the only antipsychotic with proven efficacy (Remington, Addington et al. 2017) Substantial side-effects Side Effect Prevalence Agranulocytosis Rare (<1%) Constipation 60% Myocarditis <5% CAMH houses the largest clozapine clinic in North America (~750 patients) Goal to double volume over a 5-year period 3
4 Problem Identification Problem Identification Clinical symptoms of myocarditis noted in patients treated with clozapine An expert was consulted who determined that the cause was myocarditis Agranulocytosis is the only standard monitoring for clozapine treatment Why is this Important? Clozapine-induced Myocarditis is a potentially fatal yet likely under diagnosed complication of Clozapine therapy Incidence estimated ~ 3% Develops within the first 4 weeks of Clozapine initiation and titration Hypersensitivity reaction with a fatality rate of 10% 4
5 Baseline Workflow Review and stop treatment Alternative treatment prescribed Can rechallenge patient after 1 year Yes Patient presents with TRS Decision to prescribe Clozapine Clozapine order(s) entered Myocarditis symptoms? No Continue treatment 5
6 Myocarditis Monitoring Cardiac Troponin Positive C-Reactive Protein > 50 Suspected myocarditis 6
7 Baseline Data 100% 90% Nov 2013 Oct 2014 Myocarditis Monitoring Protocol 4.2% Clozapine-naïve Patients with Myocarditis Monitoring Protocol Cardiac Specialist 80% Percentage of Patients 70% 60% 50% 40% 30% 20% 10% 0% 17% 0% 0% 0% 0% 0% 0% 0% 0% n = 1 0% 0% 0% Nov-13 Dec-13 Jan-14 Feb-14 Mar-14 Apr-14 May-14 Jun-14 Jul-14 Aug-14 Sep-14 Oct-14 Month 7
8 Objectives Standardize myocarditis monitoring protocol for Clozapine-naïve patients Increase compliance to myocarditis monitoring protocol Discontinue Clozapine for patients showing warning signs of myocarditis Streamline ordering process to save clinician time and prevent errors 8
9 Solution Selection CAMH identified a method to increase myocarditis monitoring for Clozapine patients. The implementation of I-CARE provided an opportunity to standardize care through order sets. -Decision to standardize practice through order sets was made through the Hospitalist User Group and the Pharmacy and Therapeutics Committee Clinician familiarity Dynamic reporting Communication tools Existing change management Tracking and feedback Standardized practice Existing governance Standardized documentation 9
10 Interventions Policy Order Sets Mandatory Fields (Locking) Included Myocarditis monitoring protocol into Clozapine policy (Oct. 2014) Integrated Myocarditis monitoring protocol into I-CARE order sets (Nov. 2014) Reinforced education with cardiology expert (Apr. 2015); monitoring protocol elements made mandatory within I-CARE order sets (Jun. 2015) 10
11 Strategic Governance High-level Decisions Executive Leadership Team CEO Medical Advisory Committee Physician in Chief Mid-Level Decisions Pharmacy & Therapeutics Dir. Pharmacy Health Information Interdisciplinary Committee Dir. Interprofessional Practice Dir. Medical Informatics Clinical Care Committee Dir. Interprofessional Practice Chief Medical Officer Order Sets Sub-Committee Dir. Medical Informatics Pharmacist Physician / Hospitalist User Groups Dir. Medical Informatics Lead Hospitalist Practice Adoption & Optimization Council Manager, Clinical Education Advanced Practice Clinical Lead Collaborative Practice Advisory Committee Chief of Nursing Data and Reporting Governance Committee (ELT Sub-Committee) Exec. Dir. Performance Improvement Med. Dir. Performance Improvement Clinical Applications Change Advisory Board Sr. Manager, Clinical Applications Integrated Health Record Council Dir. Clinical Information Systems APPROVED 11 ** Advisory / Working Groups established as required
12 End-User Involvement Integrated Health Record Committee Hospitalist User Group Physician User Group Chairs: Dir. Interprofessional Practice, Dir. Medical Informatics Includes clinicians and other stakeholders Initial approval of need Chair: Medical Head, Hospitalist Services Developers and subject matter experts for Clozapine Order Sets Representation from physicians, nurses, Pharmacy, Professional practice, and Health Records Chair: Chief Medical Information Officer Representation of front-line physicians Contains 15 physicians from throughout CAMH Pharmacy & Therapeutics Co-chairs: Appointed Physician and Dir. Pharmacy Owners and approvers of Order Set Includes a minimum of 6 physicians, 4 pharmacists 12
13 Revised Workflow Can rechallenge patient after 1 year Alternative treatment prescribed Review and stop treatment Abnormal Patient presents with TRS Decision to prescribe Clozapine Pre- Clozapine Initiation Order Set (Baseline)* Select Clozapine with Titration or Clozapine without Titration Order Set* Mandatory blood work for 4 weeks* Results normal or abnormal? Normal Continue treatment Health IT used within intervention* 13
14 Mandatory Monitoring Protocol Pre-initiation Baseline ECG, CRP, and Troponin Identification of pre-existing cardiac disease Troponin lab test CRP lab test 14
15 Mandatory Monitoring Protocol Post-initiation Weekly clinical assessments CRP and Troponin monitoring x 4 weeks Regular Agranulocytosis monitoring * Troponin lab test CRP lab test 4 week duration 15
16 Effect of Interventions on Data Policy Order Sets Mandatory Fields (Locking) Intervention Included Myocarditis monitoring protocol into Clozapine policy (Oct. 2014) Integrated Myocarditis monitoring protocol into I-CARE order sets (Nov. 2014) Reinforced education with cardiology expert (Apr. 2015); monitoring protocol elements made mandatory within I-CARE order sets (Jun. 2015) Effect Increased clinical awareness and regulations to educate staff about clozapine-induced myocarditis and the effective monitoring protocol Integration of monitoring protocol increased speed of ordering and provided a visual reminder about the monitoring protocol for clinicians Increased clinical awareness and enforced regulations to standardize practice for Clozapine-naïve patients 16
17 Post- Adherence Data Nov 2013 Oct 2014 Nov 2014 May 2018 Myocarditis Monitoring Protocol 4.2% 97.0% 110% 100% 90% Clozapine-naive Patients with Myocarditis Monitoring Protocol Policy 88% Order Sets Locking 100% 100% 100% 89% 100% 95% 100% 100% 100% 100% 97% 94% 89% 100% Percentage of Patients 80% 70% 60% 50% 40% 30% Pre-implementation Post-implementation 20% 10% 0% 0% 0% 0% 2013 Q Q Q2 7% 2014 Q Q Q Q Q Q Q Q2 Calendar Quarter 2016 Q Q Q Q Q Q Q Q2 17
18 Post- Outcome Data 30 Number of patients discontinued from Clozapine due to suspected Myocarditis 25 Number of Patients Nov Oct 2014 Nov May
19 16 Discontinued Patient Demographics Number of Clozapine Patients with Myocarditis Risk by Age and Sex Female Male 14 Number of Patients *13.5% Less than to to to to 64 Age *13 / 96 (13.5%) of males aged 21 to 32 discontinued 19
20 Return on Investment Patients on Clozapine with Myocarditis Monitoring n = 27 Cost averted = $108,756 n =283 Flagged as at risk and taken off Clozapine No risk Twenty-seven Clozapine-naïve patients had suspected myocarditis detected in early stages. Savings = (Cost of adverse event * # of patients detected) 20
21 Return on Investment 27 patients removed from Clozapine due to myocarditis warning signs (3 lives saved) Able to measure the true incidence (8.6%) of Clozapine-induced myocarditis; 27 patients removed from Clozapine due to warning signs Clinicians are able to more easily screen for Clozapine associated Myocarditis Developed guidelines for Clozapine cessation and reintroduction CAMH is locally leading the way for Clozapine-induced myocarditis monitoring and we expect uptake on a regional and national level after publishing 21
22 Lessons Learned Policy change can be supported by health IT to support adoption and enforcement Order sets are effective at driving adoption of mandatory protocols Data sharing with clinicians is an effective method for practice awareness 22
23 Thank You
Buprenorphine Order Set and Rapid Access Referral. Copyright 2017, CAMH
2 Buprenorphine Order Set and Rapid Access Referral 1 Agenda Problem Identification / Identification Importance / Importance Baseline Workflow Baseline Workflow Baseline Data Baseline Data Objectives Solution
More informationTreating Emergency Room Opioid Withdrawal with Buprenorphine
Treating Emergency Room Opioid Withdrawal with Buprenorphine Monday, February 11th (3:45pm 4:30pm) Room W314B Christine Bucago, Advanced Practice Clinical Leader (Nursing), CAMH Jane Paterson, Director,
More informationKansas EMS Naloxone (Narcan) Administration
Kansas EMS Naloxone (Narcan) Administration Executive Summary Kansas Board of Emergency Medical Services August 217 The following pages denote an ongoing trending of naloxone administration by Kansas Emergency
More informationBuilding Capacity for Smoking Cessation Treatment Within Primary Care Teams
Building Capacity for Smoking Cessation Treatment Within Primary Care Teams Justine Mascarenhas, MSc and Janine Fitzpatrick, MCogSc Investigators: Dr. Peter Selby and Dr. Laurie Zawertailo STOP Program,
More informationCollaborating to Implement Evidence-Based Medicine Tools. The St. John Sepsis Agent and the Interdisciplinary Sepsis Advisor
Collaborating to Implement Evidence-Based Medicine Tools The St. John Sepsis Agent and the Interdisciplinary Sepsis Advisor Learning Objectives Describe an effective implementation strategy for clinical
More informationTRANSFORMING STROKE CARE IN THE CAPITAL: THE LONDON STROKE STRATEGY
TRANSFORMING STROKE CARE IN THE CAPITAL: THE LONDON STROKE STRATEGY LUCY GROTHIER Director South London Cardiac and Stroke Network lucy.grothier@slcsn.nhs.uk 27 th May 2011 Gaps in London stroke care GAPS
More informationSession #206, March 8, 2018 Susan J. Kressly, MD, FAAP, Kressly Pediatrics Dr. Jacques Orces, D.O., Nicklaus Children s Hospital
Improving Preventative Care in Pediatrics through Health and Technology: A Davies Story Session #206, March 8, 2018 Susan J. Kressly, MD, FAAP, Kressly Pediatrics Dr. Jacques Orces, D.O., Nicklaus Children
More informationTeaming Up for Safer Pain Management: Strategies for Effective Collaboration
Teaming Up for Safer Pain Management: Strategies for Effective Collaboration Noah Nesin, MD, FAAFP, Vice President of Medical Affairs, Penobscot Community Health Care Felicity Homsted, PharmD, DPLA, Chief
More informationTexas Vendor Drug Program Specialty Drug List Process. February 2019
Texas Vendor Drug Program Specialty Drug List Process February 2019 Table of Contents Table of Contents...1 1 About the Specialty Drug List...2 1.1 Information for Pharmacies... 2 1.2 Information for Managed
More informationReducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital:
Reducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital: Eugenio H. Zabaleta, Ph.D. Clinical Chemist OhioHealth Mansfield Hospital Reducing Readmissions and Improving Outcomes at
More informationMeasure Up/Pressure Down Medical Group Success
Measure Up/Pressure Down Medical Group Success Deborah A. Molina, MPA, MBA Manager, Quality Jamie L. Reedy, MD, MPH Medical Director, Population Health Laura Balsamini, Pharm D, BCPS Director, Pharmacy
More informationThe Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England
The Infection Control Doctor and Clostridium difficile infection Dr David R Jenkins University Hospitals of Leicester NHS Trust, England 250 200 150 100 50 0 Monthly cases of Clostridium difficile (UHL
More informationWilliam Osler Health System
William Osler Health System Implementation of a Standardized approach to Delirium Assessment, Prevention & Management Cohort 1: Stephanie Jarvis, CNS, Seniors Health System Kuldeep Chahal, ELS, Hospital
More informationFlu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance
Flu Watch MMWR Week 3: January 14 to January 2, 218 All data are provisional and subject to change as more reports are received. Geographic Spread South Carolina reported widespread activity this week.
More informationBest Practices in Managing Patients with Rheumatoid Arthritis. Summit Medical Group. Standardizing Protocols and Educating Providers
Best Practices in Managing Patients with Rheumatoid Arthritis Summit Medical Group Standardizing Protocols and Educating Providers Organizational Profile Summit Medical Group, established in 1929, is the
More informationSuccessful Falls Prevention in Aged Persons Mental Health. Reducing the risk and decreasing severity of outcome
Successful Falls Prevention in Aged Persons Mental Health Reducing the risk and decreasing severity of outcome Vahitha Koshy Seema Dua Elda Kimberlee Introduction Unit 3- Acute Aged Mental Health inpatient
More informationFlu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance
Flu Watch MMWR Week 4: January 21 to January 27, 218 All data are provisional and subject to change as more reports are received. Geographic Spread South Carolina reported widespread activity this week.
More informationReducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital
Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital Dawn Waddell, PharmD, BCPS Clinical Pharmacy Manager Lisa Kingdon, PharmD, BCPS Clinical Pharmacy Specialist Dawn Waddell
More informationWhat might help reduce waiting times in CAMHS?
What might help reduce waiting times in CAMHS? Bill Williams, General Manager and IAPT Project Lead, Tower Hamlets CAMHS Dr Rebecca Adams, Consultant Child and Adolescent Psychiatrist, Tower Hamlets CAMHS
More informationSTRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS.
STRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS. Acknowledgements This project was fully funded by Center For Disease Control
More informationFaster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes
Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes Organisation Name: Ko Awatea, Counties Manukau Health Presenter: Bob Diepeveen HRT 1520 Innovations
More informationNorth Dakota Board of Pharmacy
North Dakota Board of Pharmacy Updates on Drug Abuse Trends, the PDMP and Medical Marijuana Mark J. Hardy, Pharm D Executive Director Disclosure Statement I have no conflict of interests to report Objectives
More informationAn Evaluation of the DoD Transdermal Fentanyl Pharmacy Edit. LTC Stacia Spridgen, MSC, USA Director, DoD Pharmacoeconomic Center
An Evaluation of the DoD Transdermal Fentanyl Pharmacy Edit LTC Stacia Spridgen, MSC, USA Director, DoD Pharmacoeconomic Center 1 TRICARE Eligible Beneficiaries Monthly Average, FY08 Retirees & Family
More informationSleep Market Panel. Results for June 2015
Sleep Market Panel Results for June 2015 Notes: o This is a monthly trending report of panel member data along with additional analysis by: Sleep labs affiliated with Hospitals vs. Independent Labs o Hospital
More informationInstitute of Quality Leadership AMGA
Institute of Quality Leadership AMGA Ajay Sahajpal, MD Director Abdominal Transplant and Hepatobiliary Program Bradley Kruger, VP Operations ASLMC Laura Spurr, Director Clinical Transformation and Operations
More informationArkansas Prescription Monitoring Program
Arkansas Prescription Monitoring Program ONE YEAR UPDATE Scott Pace, Pharm.D., Esq. Special Thanks Thanks to Denise Robertson at the Arkansas Department of Health for supplying the PMP data for this presentation
More informationImplementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events. September 13, 2016
Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events September 13, 2016 St Joseph s Health Fast Facts Founded 1869 by Sisters of St. Francis Patient Volumes (2014) Inpatient
More informationAn Overview of a Provincial Appropriateness of Care Initiative: A Provincial Collaborative Supporting Appropriate, Affordable, and Accessible Care
An Overview of a Provincial Appropriateness of Care Initiative: A Provincial Collaborative Supporting Appropriate, Affordable, and Accessible Care John G. Abbott Deputy Minister, Department of Health and
More informationColorectal Cancer- QI process and clinic success: A Case Study at Atascosa Health Center
Colorectal Cancer- QI process and clinic success: A Case Study at Atascosa Health Center Kaela Momtselidze Health Systems Manager Primary Care Systems American Cancer Society Sheri Frank Director of Corporate
More informationThe Opioid Addiction Emergency In Virginia June 8, 2017
The Opioid Addiction Emergency In Virginia June 8, 2017 Marissa J. Levine, MD MPH State Health Commissioner Virginia Department of Health Chronic Disease of Addiction Definition: A primary, chronic disease
More informationJan Feb Mar Apr May Jun Jul Aug Sep X X X X X X X. Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov X X X X X X X X X X X X X
Primary Prevention Breast Cancer Prevention Member: Mammography reminder letters to female members ages 51.5-74 who are overdue to get a mammogram Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Providers:
More informationImprovement Initiative for Patient Falls Susan Moffatt-Bruce, B.Sc. (Hon), M.D., Ph.D., FRCS(C), FACS, MBOE, Chief Quality and Patient Safety Officer
Improvement Initiative for Patient Falls Susan Moffatt-Bruce, B.Sc. (Hon), M.D., Ph.D., FRCS(C), FACS, MBOE, Chief Quality and Patient Safety Officer Amy M. Knupp MSN, RN, CNS, CPPS, Director of Nursing
More informationESPA Directorate KPI Report: Quarter 1,
ESPA Directorate KPI : 2015 2016 Quarter 1, Compiled by ESPA Operations Manager The Key Performance Indicators (KPIs) detailed in this report give direction to the ESPA Directorate and its activities.
More informationTherapeutics Initiative A SHORT HISTORY
Therapeutics Initiative A SHORT HISTORY Therapeutics Initiative, 1994 (10 individuals) Mission: To provide physicians and pharmacists with up-to-date, evidence-based, practical information on prescription
More informationStrategic overview of sexual health procurement Haringey and London
Strategic overview of sexual health procurement Haringey and London Sarah Hart : March 2017 2 Context for redesign of sexual health services in Haringey and London From July 2017 there will be a new offer
More informationVIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC
1 VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC Virginia Association of Counties November 14, 2016 The Honorable William A. Hazel, Jr., M.D. Secretary of Health and Human Resources 1999 - Estimated drug
More informationBJA Performance Measures
BJA Performance Measures Timothy J. Willis, Ph.D. Senior Research Associate, CSR, Inc. timothy.willis@ojp.usdoj.gov (202) 514-8045 At the end of this session you will be able to: 1. Explain the value of
More information4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP
New Mexico s Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy New Mexico and the PMP In 2012, New Mexico had the 3 nd Highest Overdose Death Rate in Nation.! 492 Deaths or a rate of 23.6
More informationBudnitz DS et al. NEJM Background
Camille P. Vaughan, MD, MS Associate Section Chief for Research, Geriatrics & Gerontology Investigator, Birmingham/Atlanta VA GRECC Assistant Professor Division of General Medicine & Geriatrics Emory University
More informationThe Impact of Clinical Decision Support (CDS) Tools on Catheter Associated Urinary Tract Infections (CAUTI) January 22, 2010.
4 th Annual NDNQI Conference The Impact of Clinical Decision Support (CDS) Tools on Catheter Associated Urinary Tract Infections (CAUTI) January 22, 2010 UPMC St Margaret Bonnie B. Anton, MN RN antonbb@upmc.edu
More informationExecutive Summary. Classes Under Review: Analysis:
Outcome Report on MHQAC Edits Classes Under Review: Analysis: Atypical Antipsychotics, SSRIs, SNRIs, Antianxietals, Hypnotics, and Drugs to Treat ADD/ADHD Utilization and Cost Trends: Pre and Post Implementation
More informationRTT Exception Report
Appendix 3 RTT Exception Report 1. Purpose To provide a summary of factors impacting on 18 week RTT performance and a revised forecast of red rated performance for Quarter 2 2015/16 for the admitted pathway.
More informationOrgan Donation Breakthrough Collaborative Institute of Medicine
Organ Donation Breakthrough Collaborative Institute of Medicine June 20, 2005 Jade Perdue, M.P.A Department of Health and Human Services Health Resources and Services Administration Healthcare Systems
More informationMcLean ebasis plus TM
McLean ebasis plus TM Sample Hospital (0000) Report For Qtr HBIPS Core Measures McLean Hospital 115 Mill Street Belmont, MA 02478 1 2012 Department of Mental Health Services Evaluation Tel: 617-855-3797
More informationHealth Equity Workgroup. January 18, 2018
Health Equity Workgroup January 18, 2018 Health Equity Workgroup Co-Chairs Fleda Mask Jackson, PhD Founder, Save 100 Babies President and CEO, Majaica, LLC University Affiliate, Columbia University Arthur
More informationTrust Board of Directors Public. Denise Gale. For Assurance and Information NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE
NLG(18)014 DATE OF MEETING 30 January 2018 REPORT FOR Trust Board of Directors Public REPORT FROM Richard Sunley, Deputy Chief Executive CONTACT OFFICER Denise Gale SUBJECT Cancer Performance and Backlog
More informationAUCKLAND REGIONAL ALCOHOL FORUM. 2 June 2011
AUCKLAND REGIONAL ALCOHOL FORUM 2 June 2011 Auckland Council Auckland governance framework: New local government structure from 1 Nov 2010 The new structure is both simple/ complex Simple One organisation,
More informationFGSZ Zrt. from 28 February 2019 till 29 February 2020 AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS
AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS FIRM CAPACITY - First Monday of July 01.06.2019* 01.07.2019 07:00 01.10.2019 04:00 01.10.2020 04:00 2019/2020 01.10.2020 04:00 01.10.2021
More informationOverview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station
Click here for the corrections made < Reference > December 3, 212 Tokyo Electric Power Company Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station * As of
More informationReducing Falls Causing Harm in Older People with Dementia. Professor Tony Elliott South Staffordshire and Shropshire FT
Reducing Falls Causing Harm in Older People with Dementia Professor Tony Elliott South Staffordshire and Shropshire FT Project Site 16 bedded Dementia Inpatient Unit Acute admissions from home, DGHs or
More informationLeeds West CCG Paediatric asthma project. January 2015-January 2017
Leeds West CCG Paediatric asthma project. January 2015-January 2017 Aims to raise asthma awareness improve care reduce emergency attendances and unplanned admissions to secondary care for children with
More informationUT HEALTH S RESPONSE TO
UT HEALTH S RESPONSE TO THE OPIOID CRISIS Clinical Safety & Effectiveness Cohort # 21 Team 10 San Antonio THE TEAM Team Leaders: Fred Campbell, Rudy Garza, Samir Patel, Tyler Roe Team Members: Mysti Schott,
More informationSouth West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation
Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance Peninsula Cancer Alliance South West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation Peninsula Thoracic-Oncology
More informationIMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE. A Clinical Quality Improvement Program
IMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE A Clinical Quality Improvement Program Today: National completion rates for OTP s hover between 11 14% Retention
More informationPat Quigley,PhD,MPH,ARNP,CRRN,FAAN,FAANP. Associate Director, VISN 8 Patient Safety Center Associate Chief for Nursing Service/Research
Pat Quigley,PhD,MPH,ARNP,CRRN,FAAN,FAANP Associate Director, VISN 8 Patient Safety Center Associate Chief for Nursing Service/Research E-Mail: patricia.quigley@med.va.gov 1 Overview Formulate measurable
More informationInfluenza Surveillance Animal and Public Health Partnership. Jennifer Koeman Director, Producer and Public Health National Pork Board
Influenza Surveillance Animal and Public Health Partnership Jennifer Koeman Director, Producer and Public Health National Pork Board Outline Background on influenza surveillance in swine Case example animal
More informationCity of Vancouver s Response to the Opioid Crisis Fire Chief Darrell Reid Vancouver Fire & Rescue Services (VF&RS)
City of Vancouver s Response to the Opioid Crisis Fire Chief Darrell Reid Vancouver Fire & Rescue Services (VF&RS) Vancouver Vancouver Fire Rescue Services Opioid Crisis Background Crisis Overview April
More informationFAQs about Provider Profiles on Breast Cancer Screenings (Mammography) Q: Who receives a profile on breast cancer screenings (mammograms)?
FAQs about Provider Profiles on Breast Cancer Screenings (Mammography) Q: Who receives a profile on breast cancer screenings (mammograms)? A: We send letters and/or profiles to PCPs with female members
More informationFrom Analytics to Action
From Analytics to Action Overview So, what are we talking about here? How to make incremental changes to your digital content that will result in positive user actions Overview Rooted in the hard sciences
More informationVaccine Safety: Its everyone s business! PHO Rounds: Nov 19, 2013
Vaccine Safety: Its everyone s business! PHO Rounds: Nov 19, 2013 Tara Harris, Nurse Consultant Shelley Deeks, Medical Director Immunization and Vaccine Preventable Diseases 1 Learning objectives 1. Describe
More informationTB Outbreak in a Homeless Shelter
TB Outbreak in a Homeless Shelter Objectives Epidemiology of Outbreak Population Health Interventions Population Health Goals 2007 One active case identified Less than compliant Prolonged recovery Contact
More informationStandardizing Detection of Acute Kidney Injury in an Integrated Delivery Health System
Standardizing Detection of Acute Kidney Injury in an Integrated Delivery Health System Tarush Kothari, MD, MPH Physician Informaticist, Northwell Health Laboratories Assistant Professor in Pathology and
More informationEmergency Department Boarding of Psychiatric Patients in Oregon
College of Public Health and Human Sciences Emergency Department Boarding of Psychiatric Patients in Oregon Jangho Yoon, PhD, Jeff Luck, PhD April 25, 2017 Scope Quantify the extent of psychiatric emergency
More informationDeveloping a QAPI Program for Cardiovascular Health Improvement
Developing a QAPI Program for Cardiovascular Health Improvement Ashley Green MetaStar WiAHC Annual Conference November 5 th, 2015 Objectives The audience will be able to: Describe the purpose of HHQI s
More informationReview of Influenza Activity in San Diego County
2015 Kick the Flu Summit Review of Influenza Activity in San Diego County 2014-2015 Season Jeffrey Johnson, MPH Senior Epidemiologist Epidemiology & Immunization Services Branch Public Health Services
More informationPharmacogenomics with Clopidogrel: Does One Size Fit All?
Pharmacogenomics with Clopidogrel: Does One Size Fit All? Leah A. Sabato, PharmD PGY-1 Pharmacy Practice Resident UC Health - University of Cincinnati Medical Center leah.sabato@uchealth.com April 2015
More informationIHN-CCO DST Final Report and Evaluation
IHN-CCO DST Final Report and Evaluation Breastfeeding Support Services July 2016 to September 2018 Summary: This pilot reduced the barriers new mothers have in being able to successfully breastfeed their
More informationSaving & Changing Lives: Ochsner s Opioid Stewardship Program
Saving & Changing Lives: Ochsner s Opioid Stewardship Program What Sparked our Interest How common opioid dependency was becoming How worrisome the morbidity and mortality in becoming in patient populations
More informationAn Updated Approach to Colon Cancer Screening and Prevention
An Updated Approach to Colon Cancer Screening and Prevention Kevin Liebovich, MD Director for Quality for Gastrointestinal diseases Advocate Condell Medical Center Colon Cancer Screening and Prevention
More informationClaire Thomas, Deputy Chief Pharmacist. Tim Donaldson, Trust Chief Pharmacist. Contents. Section Description Page No.
Pharmacological Therapy Policy Practice Guidance Note Safe Prescribing of Clozapine V02 Version issued Issue 1 Jan 16 Issue 2 Nov 16 Planned review January 2019 PPT-PGN-05 Part of NTW(C)38 Pharmacological
More informationGlobal Fund Approach to Health System Strengthening
Global Fund Approach to Health System Strengthening WHO Expert consultation on positive synergies between health systems and Global Health Initiatives Geneva, 29-30 May 2008 Dr Stefano Lazzari, Director
More informationAlignment Strategies at the JPS Health Network
Improving the Patient Experience Alignment Strategies at the JPS Health Network JPS HEALTH NETWORK 537 bed hospital, Level 1 Trauma Center Tarrant County s Safety Net Hospital 15 primary care clinics 20
More informationPublication Plan 2017
Publication Plan 2017 A passion for turning high quality, independent research insights into actionable commercial intelligence. Why Spherix Global Insights? Our independent reports are designed, developed,
More informationMICHIGAN PATHOLOGY QUALITY SYSTEM (MPQS)
MICHIGAN PATHOLOGY QUALITY SYSTEM (MPQS) Divisions of Anatomic Pathology & Clinical Informatics, Department of Pathology Administrative Forum December 15, 2008 Anatomic Pathology An Introduction 81 staff
More informationPolicy Evaluation: Step Therapy Prior Authorization of Combination Inhaled Corticosteroid / Long-Acting Beta-Agonists
Drug Use Research & Management Program OHA Division of Medical Assistance Programs 500 Summer Street NE, E35; Salem, OR 97301-1079 Phone 503-947-5220 Fax 503-947-1119 Policy Evaluation: Step Therapy Prior
More informationImproving care of HIV-infected breastfeeding
Improving care of HIV-infected breastfeeding and their : Early results from the Partnership for HIV-free Survival Initiative in Uganda Tamara Nsubuga-Nyombi, URC IAS- Melbourne, Australia July 22nd, 2014
More informationOverview of Health IT in Massachusetts: Data to Inform and Improve Performance
Overview of Health IT in Massachusetts: Data to Inform and Improve Performance Office of Economic Analysis, Evaluation and Modeling & State HIE Program December 2011 Chartpack Team Office of Economic Analysis,
More informationBreast Test Wales Screening Division Public Health Wales
Breast Test Wales Screening Division Public Health Wales Programme Level Agreement with Welsh Government Quarterly Report October - December Breast Test Wales - Quarterly Report October - December Service
More informationCrisis Connections Crisis Line Phone Worker Training (Online/Onsite) Winter 2019
Crisis Connections Crisis Line Phone Worker Training (Online/Onsite) Winter 2019 20-Jan 21-Jan 22-Jan 23-Jan 24-Jan 25-Jan 26-Jan between January 14th - January 21st Please Note: The application deadline
More informationLauren DiBiase, MS, CIC Associate Director Public Health Epidemiologist Hospital Epidemiology UNC Hospitals
Lauren DiBiase, MS, CIC Associate Director Public Health Epidemiologist Hospital Epidemiology UNC Hospitals Statistics Numbers that describe the health of the population The science used to interpret these
More informationOne State s Perspective on the Management of Hepatitis C Drugs. February 27, 2015 Pavel Lavitas, PharmD, BCPS Clinical Consultant Pharmacist
One State s Perspective on the Management of Hepatitis C Drugs Pavel Lavitas, PharmD, BCPS Clinical Consultant Pharmacist Statement of Disclosure I have no relevant financial relationships that would be
More informationOpportunities Created by Diagnostic HCV and HIV Nucleic Acid Tests
Opportunities Created by Diagnostic HCV and HIV Nucleic Acid Tests Ann Winters, MD Medical Director, Viral Hepatitis Program, Bureau of Communicable Disease, New York City Department of Health and Mental
More informationCincinnati Children s Hospital Medical Center PHO/OVPCA Constipation Initiative Monthly Report February 2018
Cincinnati Children s Hospital Medical Center PHO/OVPCA Constipation Initiative Monthly Report February 2018 Aim: Project focus to embed evidence based protocol for the treatment of Constipation in the
More informationFall Reduction in the Christus Santa Rosa ACE Unit
Clinical Safety & Effectiveness Cohort # 7 Fall Reduction in the Christus Santa Rosa ACE Unit Educating for Quality Improvement & Patient Safety Project Milestones Milestone Date Team created January 2011
More informationHIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE
HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE Site C Youth clinic HIV care pathway DAY 1 Test HIV + PIMA point of care CD4 count in in 3-5 days initiation + in session 3 session 4 1 month Youth Club
More informationEvaluation of National Academic Detailing Service on Naloxone Kit Prescription Rates in the Veterans Health Administration
Evaluation of National Academic Detailing Service on Naloxone Kit Prescription Rates in the Veterans Health Administration Melissa LD Christopher, PharmD National Director Academic Detailing Program Office
More informationEDINBURGH HEALTHCARE NHS TRUST. 4 Edinburgh Healthcare NHS Trust Printed Material,
Introduction 1 Board Minutes and Papers, 1994-1999 2 Related Board Papers, 1995-2001 3 Administrative Material, 1997-2001, n.d. 4 Edinburgh Healthcare NHS Trust Printed Material, 1995-1997 5 General Strategy
More informationStrengthening Health Systems for an AIDS-Free Generation 4th Annual IAS/IAC Pre-conference Meeting WASHINGTON, DC JULY 20-21, 2012
Strengthening Health Systems for an AIDS-Free Generation 4th Annual IAS/IAC Pre-conference Meeting WASHINGTON, DC JULY 20-21, 2012 Challenges for Further Decentralization of HIV Treatment in Tanzania David
More informationInpatient Delirium Management: A Quality Improvement Project for Hospitalized Veterans. IIndiana Nursing Summit
Inpatient Delirium Management: A Quality Improvement Project for Hospitalized Veterans IIndiana Nursing Summit November 5, 2018 At the conclusion of this presentation, participants will be able to: Identify
More informationInpatient Delirium Management: A Quality Improvement Project for Hospitalized Veterans
Inpatient Delirium Management: A Quality Improvement Project for Hospitalized Veterans IIndiana Nursing Summit November 5, 2018 Veteran Health Indiana At the conclusion of this presentation, participants
More informationIntegrated Care Pathway (ICP) for the. Management of clozapine INPATIENT INITIATION
Document Reference MM 048 Integrated Care Pathway (ICP) for the Management of clozapine INPATIENT INITIATION Surname Title Address Forenames Date of Birth RT/NHS number Care Co-ordinator GP CS number Consultant
More informationThe Geisinger ProvenCare Experience. Heal Teach Discover Serve
The Geisinger ProvenCare Experience Division of Clinical Effectiveness A strong business case for quality Not all appropriate care is rendered Unnecessary care is being provided Compliance with evidence-based
More information18 Week 92% Open Pathway Recovery Plan and Backlog Clearance
18 Week 92% Open Pathway Recovery Plan and Backlog Clearance Page 1 of 6 17.05.2012 1.0 Background 18-Week 92% Open Pathway RECOVERY PLAN The Trust has achieved compliance against the admitted and non-admitted
More informationKENT BISHOP M.D. ProMedica Chief Experience Officer President Women s Service Line
KENT BISHOP M.D. ProMedica Chief Experience Officer President Women s Service Line 1 WHEN A VISION TAKES SHAPE. 2 3 4 Modern Facilities Clinical Service Lines Quality/ Safety Mental Health Clinical Research
More informationThe Greater Manchester Stroke Operational Delivery Network
The Dr Jane Molloy Clinical Lead What is the GMSODN? Established in July 2015 Only Stroke ODN in the country Non-statutory body constituted from all public sector stroke provider organisations across Greater
More informationHow a Signs of Safety approach is changing practice in Norfolk. Andrea Brown Principal Social Worker Community Care- Live Tuesday 10 th May 2016
How a Signs of Safety approach is changing practice in Norfolk Andrea Brown Principal Social Worker Community Care- Live Tuesday 10 th May 2016 The Norfolk Context 2014 OFSTED What did we need to do? Address
More informationINFLUENZA IN MANITOBA 2010/2011 SEASON. Cases reported up to October 9, 2010
INFLUENZA IN MANITOBA 2/211 SEASON Cases reported up to October 9, 2 The public health disease surveillance system of Manitoba Health received its first laboratory-confirmed positive case of influenza
More informationOpioid Overdose Education and Naloxone Distribution
Opioid Overdose Education and Naloxone Distribution Emily Stoukides, PharmD PGY-2 Ambulatory Care Pharmacy Resident Nicole Brunet, PharmD, BCPP Clinical Pharmacy Specialist, Mental Health Disclosures Emily
More informationStatus of Implementing Legislation Regarding the Eastern Band of Cherokee Indians
Status of Implementing Legislation Regarding the Eastern Band of Cherokee Indians Session Law 2015 241, Section 12C.10.(h) Report to The Joint Legislative Oversight Committee on Health and Human Services
More informationAHP Musculoskeletal Service Redesign. Judith Reid MSc MMACP Consultant Physiotherapist in MSK NHS Ayrshire and Arran
AHP Musculoskeletal Service Redesign Judith Reid MSc MMACP Consultant Physiotherapist in MSK NHS Ayrshire and Arran Local Drivers Routine referral practice Via acute care, duplication Long waiting times
More information